 Mass Spectrometry
"Mass Spectrometry" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An analytical method used in determining the identity of a chemical based on its mass using mass analyzers/mass spectrometers.
| Descriptor ID |
D013058
|
| MeSH Number(s) |
E05.196.566
|
| Concept/Terms |
Mass Spectrometry- Mass Spectrometry
- Mass Spectroscopy
- Spectrum Analysis, Mass
- Analysis, Mass Spectrum
- Analyses, Mass Spectrum
- Mass Spectrum Analyses
- Spectrum Analyses, Mass
- Mass Spectrum Analysis
- Spectrometry, Mass
- Spectroscopy, Mass
|
Below are MeSH descriptors whose meaning is more general than "Mass Spectrometry".
Below are MeSH descriptors whose meaning is more specific than "Mass Spectrometry".
This graph shows the total number of publications written about "Mass Spectrometry" by people in this website by year, and whether "Mass Spectrometry" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1990 | 0 | 1 | 1 | | 1991 | 0 | 3 | 3 | | 1992 | 2 | 3 | 5 | | 1993 | 0 | 1 | 1 | | 1994 | 0 | 4 | 4 | | 1995 | 2 | 5 | 7 | | 1996 | 1 | 8 | 9 | | 1997 | 1 | 5 | 6 | | 1998 | 3 | 8 | 11 | | 1999 | 2 | 9 | 11 | | 2000 | 1 | 10 | 11 | | 2001 | 2 | 6 | 8 | | 2002 | 0 | 12 | 12 | | 2003 | 3 | 9 | 12 | | 2004 | 3 | 17 | 20 | | 2005 | 4 | 18 | 22 | | 2006 | 6 | 13 | 19 | | 2007 | 4 | 13 | 17 | | 2008 | 6 | 19 | 25 | | 2009 | 4 | 19 | 23 | | 2010 | 7 | 24 | 31 | | 2011 | 9 | 28 | 37 | | 2012 | 4 | 25 | 29 | | 2013 | 6 | 16 | 22 | | 2014 | 6 | 19 | 25 | | 2015 | 9 | 17 | 26 | | 2016 | 3 | 23 | 26 | | 2017 | 3 | 24 | 27 | | 2018 | 3 | 15 | 18 | | 2019 | 8 | 15 | 23 | | 2020 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Mass Spectrometry" by people in Profiles.
-
Chen Z, Kibler RD, Hunt A, Busch F, Pearl J, Jia M, VanAernum ZL, Wicky BIM, Dods G, Liao H, Wilken MS, Ciarlo C, Green S, El-Samad H, Stamatoyannopoulos J, Wysocki VH, Jewett MC, Boyken SE, Baker D. De novo design of protein logic gates. Science. 2020 04 03; 368(6486):78-84.
-
Wang H, Lu L, Chen H, McKenna AM, Lu J, Jin S, Zuo Y, Rosario-Ortiz FL, Ren ZJ. Molecular Transformation of Crude Oil Contaminated Soil after Bioelectrochemical Degradation Revealed by FT-ICR Mass Spectrometry. Environ Sci Technol. 2020 02 18; 54(4):2500-2509.
-
Guard SE, Ebmeier CC, Old WM. Label-Free Immunoprecipitation Mass Spectrometry Workflow for Large-scale Nuclear Interactome Profiling. J Vis Exp. 2019 11 17; (153).
-
Conley JM, Berg LJ. TCR signaling: it's all about the numbers. Nat Immunol. 2019 11; 20(11):1415-1416.
-
Shokati T, Hartmann M, Davari B, Klawitter J, Klawitter J, Christians U. Temsirolimus metabolic pathways revisited. Xenobiotica. 2020 Jun; 50(6):640-653.
-
Sonn BJ, Saben JL, McWilliams G, Shelton SK, Flaten HK, D'Alessandro A, Monte AA. Predicting response to lisinopril in treating hypertension: a pilot study. Metabolomics. 2019 10 03; 15(10):133.
-
Semova I, Levenson AE, Krawczyk J, Bullock K, Williams KA, Wadwa RP, Shah AS, Khoury PR, Kimball TR, Urbina EM, de Ferranti SD, Bishop FK, Maahs DM, Dolan LM, Clish CB, Biddinger SB. Type 1 diabetes is associated with an increase in cholesterol absorption markers but a decrease in cholesterol synthesis markers in a young adult population. J Clin Lipidol. 2019 Nov - Dec; 13(6):940-946.
-
Moore HB, Culp-Hill R, Reisz JA, Lawson PJ, Sauaia A, Schulick RD, Del Chiaro M, Nydam TL, Moore EE, Hansen KC, D'Alessandro A. The metabolic time line of pancreatic cancer: Opportunities to improve early detection of adenocarcinoma. Am J Surg. 2019 12; 218(6):1206-1212.
-
Hippensteel JA, Uchimido R, Tyler PD, Burke RC, Han X, Zhang F, McMurtry SA, Colbert JF, Lindsell CJ, Angus DC, Kellum JA, Yealy DM, Linhardt RJ, Shapiro NI, Schmidt EP. Intravenous fluid resuscitation is associated with septic endothelial glycocalyx degradation. Crit Care. 2019 07 23; 23(1):259.
-
Pegram LM, Liddle JC, Xiao Y, Hoh M, Rudolph J, Iverson DB, Vigers GP, Smith D, Zhang H, Wang W, Moffat JG, Ahn NG. Activation loop dynamics are controlled by conformation-selective inhibitors of ERK2. Proc Natl Acad Sci U S A. 2019 07 30; 116(31):15463-15468.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|